NASDAQ · Biotechnology

Allena Pharmaceuticals, Inc. (ALNA) Stock

$0.08 +14.29% NASDAQ: ALNA Healthcare

Allena Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and market introduction of orally administered enzyme therapies.

Valuation

MetricValue
Price$0.08
Market Cap$0
P/E Ratio-0.08
P/B Ratio0.13
P/S Ratio0.00
EPS (TTM)$-1.03
52-Week High—
52-Week Low—
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-173.68%
ROA-94.29%
ROCE-169.49%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.05
Current Ratio2.06

Annual Financials (USD)

Metric20172018201920202021
Revenue$0$0$0$0$0
Operating Profit$-21.0M$-36.0M$-47.0M$-32.0M$-32.0M
Net Profit$-22.0M$-36.0M$-47.0M$-33.0M$-33.0M
EPS$-4.79$-1.72$-2.13$-1.01$-1.03
Op Margin—————

Balance Sheet (USD)

Metric20172018201920202021
Total Assets$96.0M$65.0M$34.0M$39.0M$35.0M
Total Liabilities$13.0M$16.0M$17.0M$16.0M$16.0M
Cash$94.0M$62.0M$30.0M$35.0M$30.0M
Borrowings$9.0M$10.0M$10.0M$10.0M$1.0M

Latest News

Micron and Sandisk Are Surging: Can the Rally Last Through 2027? Motley Fool · Jul 23, 2026 Net Asset Value(s) Business Wire · Jul 23, 2026 Retiring With Lots of Savings? 2 Social Security Claiming Strategies to Look At. Motley Fool · Jul 23, 2026 Arista Networks Insider Sold Shares Worth $7,388,872, According to a Recent SEC Filing MT Newswires · Jul 23, 2026 Go Global, Go Systemic: China Asset Management Unveils Active Investment Research 5.0 GlobeNewswire · Jul 23, 2026

Cash Flow (USD)

Metric20172018201920202021
Operating Cash Flow$-21.0M$-32.0M$-44.0M$-28.0M$-46.0M
Investing Cash Flow$23.0M$-1.0M$0$-1.0M$-1.0M
Financing Cash Flow$67.0M$-1.0M$12.0M$34.0M$41.0M
Net Cash Flow$69.0M$-33.0M$-32.0M$5.0M$-5.0M
Free Cash Flow$-21.0M$-32.0M$-44.0M$-29.0M$-46.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.92
FCF Yield—
Quick Ratio2.11
Interest Coverage-63.40
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APGNApexigen, Inc. $0.39 +8.48% -0.24 $9.57M 0.00%
CHROChannel Therapeutics Corporation $1.35 +7.14% -0.05 $8.90M 0.00%
CRVO $2.56 -3.76% -1.09 $23.70M 0.00%
CSCICOSCIENS Biopharma Inc. $2.72 +0.00% -0.35 $8.57M 0.00%
EPIXESSA Pharma Inc. $0.20 -1.85% -0.87 $9.52M 0.00%

About Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and market introduction of orally administered enzyme therapies. Operating within the United States, the firm is dedicated to addressing debilitating metabolic and renal conditions, particularly those that are rare and severe. Its primary therapeutic candidate, ALLN-346, is an innovative enzyme designed to break down urate. This treatment is specifically aimed at individuals experiencing hyperuricemia and gout, especially when these conditions coexist with advanced chronic kidney disease. Established in 2011, Allena Pharmaceuticals maintains its corporate headquarters in Newton, Massachusetts.

the stock is valued at a price-to-earnings (P/E) ratio of -0.08, price-to-book of 0.13, price-to-sales of 0.00.

On profitability, Allena Pharmaceuticals, Inc. generates a return on equity (ROE) of -173.68%, return on capital employed of -169.49%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.allenapharma.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides